Webbläsaren som du använder stöds inte av denna webbplats. Alla versioner av Internet Explorer stöds inte längre, av oss eller Microsoft (läs mer här: * https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Var god och använd en modern webbläsare för att ta del av denna webbplats, som t.ex. nyaste versioner av Edge, Chrome, Firefox eller Safari osv.

Stable Peptide of the Endogenous Opioid Enkephalin Precursor and Breast Cancer Risk.

Författare

Summary, in English

In experimental studies, enkephalins (ENKs) and related opioids have been implicated as negative regulators of breast cancer development by enhancing immune-mediated tumoral defense as well as directly inhibiting cancer cells. We hypothesized that plasma levels of ENKs are predictive of the long-term breast cancer risk. Therefore, our objective was to measure pro-ENK A, a surrogate for mature ENK, and evaluate its predictive value for the development of breast cancer in a large population of middle-aged women and an independent study population.

Ämne

  • Cancer and Oncology

Status

Published

Forskningsgrupp

  • Tumor microenvironment
  • Cardiovascular Research - Hypertension
  • Diabetes - Cardiovascular Disease
  • Surgery
  • Genomics, Diabetes and Endocrinology
  • Internal Medicine - Epidemiology
  • Cardiovascular Research - Epidemiology

ISBN/ISSN/Övrigt

  • ISSN: 1527-7755